Trump Counts On China To Deliver In The Day Of The Coronavirus
President dismisses fears of drug shortages as White House prepares to deliver US from dependence on China’s pharmaceutical manufacturing complex.
You may also be interested in...
Guidelines for US health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
Efficacy trials are under way and one supplier already has said it would restart production to meet the anticipated demand.
USP reference standard sales showed slow resumption of API manufacturing in China and less-than-expected API use in India.